Toggle light / dark theme

Korean researchers develop insect brain-inspired motion detector

The new semiconductor is expected to have some important applications in things like transportation and security systems in both industry and the public.

Korean researchers have developed a new “intelligent sensor” semiconductor that works similarly to the optic nerves of insects.


A team of researchers from Korea have developed an insect brain-inspired semiconductor that can be used as a fast, low power motion detector.

Early vocabulary size is genetically linked to ADHD, literacy, and cognition

Early language development is an important predictor of children’s later language, reading and learning skills. Moreover, language learning difficulties are related to neurodevelopmental conditions such as attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).

Children typically start to utter their first words between 10 and 15 months of age. At around two years of age, they may produce between 100–600 words, and understand many more. Each child embarks on its own developmental path of language learning, resulting in large individual differences. “Some variation in can be related to variation in the stored in our cells,” says senior researcher Beate St Pourcain, lead scientist on the study.

Prof Nadeem Sarwar — Corporate VP, Co-Founder & Head, Transformational Prevention Unit, Novo Nordisk

Professor Nadeem Sarwar is Corporate Vice President, Co-Founder and Head, Transformational Prevention Unit, Novo Nordisk (https://www.novonordisk.com/partnerin…), Co-Chair UK Dementia Mission (a UK Government Ministerial appointment) and Honorary Professor, University of Edinburgh Medical School.

Professor Sarwar joined Novo Nordisk in June 2023 as Corporate Vice President, Co-Founder and Head of Novo Nordisk’s new Transformational Prevention Unit (TPU) whose mission is to increase obesity-free life years, so people live healthier and longer lives. To achieve this, the TPU is establishing an integrated ecosystem that will deliver science-first, empowering, and scalable commercial solutions that predict and pre-empt obesity and its consequences through innovative partnerships, with solutions intending to push the boundaries of what is possible with drugs, genomics, microbiome, digital health, and behavioral science.

Professor Sarwar’s expertise stems from scientific and business models at the intersection of genomics, data sciences and digital technologies for therapeutic and health innovation and he utilizes this expertise to steer the strategy and implementation of the predictive and pre-emptive obesity solutions being developed by the TPU, spanning both R\&D and commercial strategy.

Professor Sarwar joins Novo Nordisk with extensive executive experience in academia (Cambridge, Edinburgh), pharma (Pfizer, Eisai, Novo Nordisk), biotech (Genetics Guided Demantia Discovery — G2D2), company incubation (Eisai Innovation Biolabs), and government (UK Dementia Mission). He has successfully built and led organizations across the UK, US, Japan, and Denmark; and contributed to delivery of therapeutics into clinical trials for cardiometabolic diseases, oncology, SLE, COVID-19 and neurodegeneration.

Professor Sarwar’s research has been published in leading medical journals (eg, NEJM, Lancet, JAMA), presented at international meetings (eg, American Diabetes Association; World Dementia Council), and profiled by international media (eg, BBC, Forbes). He has provided expert insights for the UK Department of Health, the World Economic Forum, and the US National Academies of Sciences.

Apart from his current position at Novo Nordisk, Professor Sarwar holds the position of Honorary Professor at the University of Edinburgh Medical School. He also currently serves on the UK Medical Research Council (MRC) Neuroscience and Mental Health Board, the UK MRC Prevention Task and Finish Group, the Health Data Industry Expert Sub-Group, and the UK Life Sciences Council.

Q&A: How a potential treatment for Alzheimer’s disease could also work for type 2 diabetes

Of the 38 million Americans who have diabetes, at least 90% have type 2, according to the Centers for Disease Control and Prevention. Type 2 diabetes occurs over time and is characterized by a loss of the cells in the pancreas that make the hormone insulin, which helps the body manage sugar.

These cells make another protein, called islet amyloid polypeptide or IAPP, which has been found clumped together in many type 2 diabetes patients. The formation of IAPP clusters is comparable to how a protein in the brains of Alzheimer’s disease patients sticks together to eventually form the signature plaques associated with that disease.

Researchers at the University of Washington have demonstrated more similarities between IAPP clusters and those in Alzheimer’s. The team previously showed that a can block the formation of small, toxic Alzheimer’s protein clusters. Now, in a recently published paper in Protein Science, the researchers have used a similar peptide to block the formation of IAPP clusters.

Thing in itself

Alex Rosenberg is professor of Philosophy at Duke University and has made several important contributions to the philosophy of science, biology, and social science.

0:00 intro.
2:53 scientism.
5:09 naturalism and the manifest image.
7:25 pragmatism.
10:40 intentionality.
12:38 objections to eliminativism and truth.
14:35 consciousness.
16:50 biological functions, purposes, and the selected effects theory.
22:28 reductionism.
28:05 causality.
31:02 multiple realizability.
35:13 math.
39:45 morality.
44:51 humanism, art, and history.

Alex Rosenberg’s website: https://alexrosenbergbooks.com/

Alex Rosenberg Books:
Reduction and Mechanism (2020)
How History Gets Things Wrong: The Neuroscience of Our Addiction to Stories (2018)
The Atheist’s Guide to Reality: Enjoying Life Without Illusions (2011)
Darwinian Reductionism (2006)
Philosophy of Science: A Contemporary Introduction (2000)

Social.
Twitter: / thinginitself__
Instagram: / thinginitself.pod.
Facebook: / 100088163125850

Alex Rosenberg | Intentionality, Evolution, and More

Alex Rosenberg is the R. Taylor Cole Professor of Philosophy at Duke University. His research focuses on the philosophy of biology and science more generally, mind, and economics.

/ friction.
/ discord.
/ frictionphilo.

00:00 — Introduction.
01:47 — Scientism.
05:16 — Naturalism.
08:08 — Methodological or substantive?
09:40 — Eliminativism about intentionality.
11:50 — Moorean shift.
13:28 — Arguments against eliminativism.
21:19 — Papineau on intentionality.
25:43 — Consciousness.
29:29 — Companions in guilt.
31:30 — Fodor and natural selection.
37:26 — No selection for?
38:16 — Properties.
39:21 — Selection for/against.
40:34 — Selection for long necks in giraffes.
42:26 — Speaking with the vulgar?
44:26 — Selection against as intensional.
47:12 — Function and selection for.
49:11 — Skepticism.
50:59 — Example.
52:06 — Mereological nihilism.
53:23 — Value of philosophy.
55:22 — Nihilism?
1:00:03 — Conclusion.

Music: PaulFromPayroll — High Rise